Final survival analysis of NSGO-AVANOVA2/ENGOT-OV24: Combination of niraparib and bevacizumab versus niraparib alone as treatment of recurrent platinum-sensitive ovarian cancer—A randomized controlled chemotherapy-free study.

Mansoor Raza Mirza, Gitte-Betina Nyvang, Bente Lund, Rene dePont Christensen, Theresa Louise Werner, Susanne Malander, Line Bjørge, Michael J. Birrer, Maarit Anttila, Gabriel Lindahl, Sakari Hietanen, Maria Dimoula, Ulla Peen, Kristine Madsen, Anja Knudsen, Synnove Staff, Nicole Buchner Vinum, Maj Kamille Kjeldsen, Elisabeth Avall-Lundqvist, Johanna Unelma Maenpaa

Research output: Contribution to journalConference abstract in journalResearchpeer-review

Original languageEnglish
JournalJournal of Clinical Oncology
Issue number15, suppl.
Pages (from-to)6012-6012
Number of pages1
Publication statusPublished - 2020
Event2020 ASCO Annual Meeting -
Duration: 29 May 202031 May 2020


Conference2020 ASCO Annual Meeting

Cite this